Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease

The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entitled Biomarkers in Chronic Kidney Disease, with the intention to identify high-risk patients. These markers do not target measurable parameters in patients but clinical endpoints that may be in turn transformed to benefits under the effect of future interventions.

Automated summary

The current healthcare concept promotes personalized treatment through biomarkers for chronic kidney disease patients. Prognostic markers based on real-world evidence aim to identify high-risk patients for better decision-making.